Cargando…

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure

Detalles Bibliográficos
Autores principales:	van der Wal, Haye H., Beverborg, Niels Grote, ter Maaten, Jozine M., Vinke, Joanna S.J., de Borst, Martin H., van Veldhuisen, Dirk J., Voors, Adriaan A., van der Meer, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2020
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319429/ https://www.ncbi.nlm.nih.gov/pubmed/32243649 http://dx.doi.org/10.1002/ejhf.1801

Ejemplares similares

Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use
por: van der Wal, Haye H, et al.
Publicado: (2019)

Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates
por: Grote Beverborg, Niels, et al.
Publicado: (2015)

A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure
por: Al-Mubarak, Ali A., et al.
Publicado: (2020)

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
por: Alnuwaysir, Ridha I. S., et al.
Publicado: (2021)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study
por: Alnuwaysir, Ridha I.S., et al.
Publicado: (2021)

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
por: ter Maaten, Jozine M., et al.
Publicado: (2023)

Urinary sodium evaluation: the missing target for diuretic treatment optimization in acute heart failure patients? Reply
por: Damman, Kevin, et al.
Publicado: (2020)

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
por: Boorsma, Eva M., et al.
Publicado: (2020)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure
por: Pandhi, Paloma, et al.
Publicado: (2021)

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
por: Bomer, Nils, et al.
Publicado: (2022)

Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del
por: Deiman, Frederik E., et al.
Publicado: (2022)

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019)

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Worsening renal function in acute heart failure in the context of diuretic response
por: Emmens, Johanna E., et al.
Publicado: (2021)

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function
por: Hoes, Martijn F., et al.
Publicado: (2018)

Clinical implications of low estimated protein intake in patients with heart failure
por: Streng, Koen W., et al.
Publicado: (2022)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations
por: Vegter, Eline L., et al.
Publicado: (2017)

Treating oxidative stress in heart failure: past, present and future
por: van der Pol, Atze, et al.
Publicado: (2018)

Pain score, desire for pain treatment and effect on pain satisfaction in the emergency department: a prospective, observational study
por: van Zanden, Judith E., et al.
Publicado: (2018)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Statins in the Treatment of Chronic Heart Failure: A Systematic Review
por: van der Harst, Pim, et al.
Publicado: (2006)

A patient with recurrent syncope—it does matter how slow and long you go
por: Roseboom, Eva, et al.
Publicado: (2023)

A patient with recurrent syncope—it does matter how slow and long you go
por: Roseboom, Eva, et al.
Publicado: (2023)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure
por: Sama, Iziah E., et al.
Publicado: (2020)

Selenium and outcome in heart failure
por: Bomer, Nils, et al.
Publicado: (2019)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
por: van der Vaart, Amarens, et al.
Publicado: (2023)

Additive value of dobutamine stress echocardiography in patients with an anomalous origin of a coronary artery
por: Lameijer, Heleen, et al.
Publicado: (2015)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

An Erythropoietin-Independent Mechanism of Erythrocytic Precursor Proliferation Underlies Hypoxia Tolerance in Sea Nomads
por: Ilardo, Melissa, et al.
Publicado: (2022)

Pathophysiological pathways in patients with heart failure and atrial fibrillation( )
por: Santema, Bernadet T, et al.
Publicado: (2021)

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
por: van Essen, Bart J., et al.
Publicado: (2022)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ag1u3eianpntjbaf9tfhskhtdv